The CHILD Trial: Hypoplastic Left Heart Syndrome Study.

Completed · Phase 1

Conditions studied: Hypoplastic Left Heart Syndrome

In brief

The objectives of this pilot study are to evaluate the feasibility and safety of intramyocardial injection of autologous c-kit+ cells during the Stage II Bidirectional Cavopulmonary Anastomosis (BDCPA) operation and to observe effects on clinical outcome including right ventricular myocardial function, severity of tricuspid regurgitation, incidence of serious adverse events, re-hospitalizations, changes in health status, the need for transplantation, or mortality.

Key facts

Study ID
NCT03406884
Run by
Joshua M Hare
People needed
25
Starts
2019-10-16
Expected to finish
2024-07-01
Last updated by the study team
2026-01-23

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.